Hiroaki Mitsuhashi Selected Research

Hiroaki Mitsuhashi Research Topics

Disease

4	Muscular Diseases (Myopathy) 09/2013 - 11/2010
3	Pneumonia (Pneumonitis) 01/2008 - 08/2003
2	Facioscapulohumeral Muscular Dystrophy 04/2018 - 02/2013
2	Myotonic Dystrophy (Dystrophia Myotonica) 03/2016 - 02/2015
2	Colorectal Neoplasms (Colorectal Cancer) 03/2016 - 01/2011
2	Muscular Dystrophies (Muscular Dystrophy) 02/2013 - 06/2011
2	Acute Lung Injury 12/2012 - 11/2011
1	Sarcoma (Soft Tissue Sarcoma) 07/2019
1	Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy) 01/2019
1	Gallbladder Diseases (Gall Bladder Disease) 04/2018
1	Obesity 04/2018
1	Disease Progression 03/2016
1	Myotonia 03/2016
1	Neoplasm Metastasis (Metastasis) 03/2016
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2016
1	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 06/2015
1	Muscle Weakness 02/2015
1	Memory Disorders (Memory Loss) 01/2015
1	Alzheimer Disease (Alzheimer's Disease) 01/2015
1	Postoperative Pain 07/2014
1	Morbid Obesity 07/2014
1	Wounds and Injuries (Trauma) 07/2014
1	Acute Cholecystitis 07/2014
1	Neoplasms (Cancer) 12/2013
1	Hearing Loss (Hearing Impairment) 02/2013
1	Myofibrillar Myopathy 04/2012
1	Intellectual Disability (Idiocy) 06/2011
1	Exanthema (Rash) 01/2011
1	Rectal Neoplasms (Rectal Cancer) 01/2011
1	Laminopathies 11/2010
1	Progeria (Hutchinson Gilford Syndrome) 11/2010
1	Lipodystrophy 11/2010
1	Cardiomyopathies (Cardiomyopathy) 11/2010
1	Autistic Disorder (Autism) 03/2007
1	Necrosis 12/2005
1	Silicosis 08/2003
1	Granuloma 08/2003
1	Inflammation (Inflammations) 08/2003
1	Muscular Atrophy (Muscle Atrophy) 07/2003
1	Atrophy 07/2003

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 03/2016 - 06/2011
2	Lamin Type A (Lamin A)IBA 01/2019 - 11/2010
2	Protein Isoforms (Isoforms)IBA 04/2018 - 08/2003
2	Interleukin-8 (Interleukin 8)IBA 11/2011 - 05/2006
2	LaminsIBA 06/2011 - 11/2010
1	Amino Acids FDA Link 07/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2016
1	Antisense OligonucleotidesIBA 06/2015
1	RNA Precursors (Precursor, mRNA)IBA 06/2015
1	RNA (Ribonucleic Acid)IBA 02/2015
1	3' Untranslated Regions (3' UTR)IBA 02/2015
1	Amyloid (Amyloid Fibrils)IBA 01/2015
1	Cysteine (L-Cysteine)FDA Link 09/2013
1	Tyrosine (L-Tyrosine)FDA Link 09/2013
1	Retinaldehyde (Retinal)IBA 02/2013
1	Cholecalciferol (Vitamin D3)FDA Link 12/2012
1	hydroxide ionIBA 12/2012
1	(2- hydroxy- 2- methyl- cyclopentanone- 5- ylidene)methyl- 9,10- secopregna- 5,7,10(19)- triene- 1,3- diolIBA 12/2012
1	FilaminsIBA 01/2012
1	ChemokinesIBA 11/2011
1	Phosphatidylcholines (Phosphatidylcholine)IBA 06/2011
1	Choline KinaseIBA 06/2011
1	emerinIBA 06/2011
1	Cetuximab (Erbitux)FDA Link 01/2011
1	ErbB Receptors (EGF Receptor)IBA 01/2011
1	SteroidsIBA 01/2011
1	SmokeIBA 01/2008
1	NeuroliginsIBA 03/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2006
1	2-aminoethylamide N- ((2- (hydroxyaminocarbonyl)methyl)- 4- methylpentanoyl)- 3- (2'- naphthyl)alanylalanineIBA 12/2005
1	EnzymesIBA 12/2005
1	Chemotactic FactorsIBA 08/2003
1	CytokinesIBA 08/2003
1	Silicon Dioxide (Silica)FDA LinkGeneric 08/2003

Therapy/Procedure

2	Laparoscopic Cholecystectomy 04/2018 - 07/2014
2	Drug Therapy (Chemotherapy) 03/2016 - 01/2011
1	Contraindications 04/2018
1	Therapeutics 06/2015
1	Operative Time 07/2014
1	Surgical Instruments (Clip) 12/2013
1	Denervation 07/2003